Allianz Asset Management GmbH - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$601,037
-2.7%
8,9480.0%0.00%0.0%
Q2 2023$617,680
-95.6%
8,948
-96.5%
0.00%
-92.3%
Q2 2022$13,885,000
+22.1%
252,464
-19.3%
0.01%
+62.5%
Q1 2022$11,375,000
+3.1%
313,016
+32.3%
0.01%0.0%
Q4 2021$11,032,000236,6820.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders